Consolidated Statement Of Cash Flows

Cytori Cell Research Institute,Inc. - Filing #7246462

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,013,409,000 JPY
-886,898,000 JPY
Interest and dividends received
444,000 JPY
285,000 JPY
Interest paid
-76,217,000 JPY
-157,860,000 JPY
Net cash provided by (used in) operating activities
-987,038,000 JPY
-1,152,230,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-8,086,000 JPY
-16,256,000 JPY
Proceeds from sale of property, plant and equipment
25,464,000 JPY
8,290,214,000 JPY
Net cash provided by (used in) investing activities
22,901,000 JPY
8,689,978,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-1,000,000 JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
3,249,000 JPY
1,000,000 JPY
Other, net
2,274,000 JPY
-33,978,000 JPY
Cash flows from financing activities
Proceeds from short-term borrowings
300,000,000 JPY
220,000,000 JPY
Repayments of short-term borrowings
-70,000,000 JPY
-650,000,000 JPY
Repayments of long-term borrowings
-53,528,000 JPY
-5,605,326,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-4,776,000 JPY
JPY
Net cash provided by (used in) financing activities
171,650,000 JPY
-7,172,572,000 JPY
Other, net
-44,000 JPY
-245,000 JPY
Net increase (decrease) in cash and cash equivalents
-792,485,000 JPY
365,176,000 JPY
Cash and cash equivalents
255,980,000 JPY
1,038,227,000 JPY
673,050,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.